Company: BGLC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001477932-25-002725
Chunk: 324

Company: BioNexus Gene Lab Corp
Filing Date: 2025-04-15
Form: 10-K
Item: Item 13
Chunk 324
---
 by the principal accountant for tax compliance, tax advice, and tax planning were:

2024 $30,197 2023 $14,763 

(4) All Other Fees

The aggregate fees billed in each of the last two fiscal years for the products and services provided by the principal accountant, other than the services reported in paragraphs (1), (2), and (3) were:

2024 $2,258 2023 $4,508 

The percentage of hours expended on the principal accountant’s engagement to audit our financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full time, permanent employees was 0%.

Audit Committee’s Pre-Approval Process

The Audit Committee of the Company reviews fees proposed by our Independent Auditor, and accordingly, all services are approved by all the members of the Committee.

 58Table of Contents

PART IV

Item 15. Exhibits, Financial Statement Schedules.

EXHIBIT INDEX

Exhibit NumberDescription1.1**Form of Underwriting Agreement  3.1**Articles of Incorporation of the Registrant, as currently in effect  3.2+Bylaws of the Registrant, as currently in effect  3.3**Certificate of Amendment filed with the Secretary of the State of Wyoming on June 7, 2017  3.4**Certificate of Amendment filed with the Secretary of the State of Wyoming on March 29, 2023  3.5**Certificate of Amendment filed with the Secretary of the State of Wyoming on June 5, 2023   3.6+ Articles of Amendment filed with the Wyoming Secretary of State on February 11, 2025.   3.7+ Articles of Amendment filed with the Wyoming Secretary of State on April 1, 2025.  4.1**Registrant’s Specimen Certificate for Common Stock  4.2**Form of Representative’s Warrant  10.1**Share Exchange Agreement between BioNexus and Chemrex  10.2**Employment Agreement with  Su-Leng Tan Lee  10.3+Director Offer Letter by and between the Registrant and Su-Leng Tan Lee  10.4+Director Offer Letter by and between the Registrant and Muhammad Azrul bin Abdul Hamid  10.5+Director Offer Letter by and between the Registrant and Jook Yuen